PAUL SCERRI SA – Trademark Portfolio
Entity Type: 03
PAUL SCERRI SA holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LOVIVE, LYMPHOFLUIDE, and PAUL SCERRI GENEVE. The owner is based in Plan-les-Ouates.
14, Chemin du Pre-Fleuri
Plan-les-Ouates 1228 , CH
Showing of trademarks Trademarks
Trademark Classifications
PAUL SCERRI SA's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does PAUL SCERRI SA have?
PAUL SCERRI SA has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does PAUL SCERRI SA file in?
PAUL SCERRI SA files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are PAUL SCERRI SA's most well-known trademarks?
PAUL SCERRI SA's registered trademark portfolio includes well-known marks such as LOVIVE, LYMPHOFLUIDE, and PAUL SCERRI GENEVE. These are among 3 currently registered trademarks in the portfolio.
What is PAUL SCERRI SA's trademark registration success rate?
PAUL SCERRI SA has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.